克罗恩病患者的韦尔尼克脑病:一个病例报告
Fatima Adamou1,2, Doua Darkaoui1,2, Hajar Koulali1,2
1Hepato-Gastroenterology, Mohammed VI University Hospital, Oujda, MAR.
Cureus
|October 25, 2023
概括
炎症性肠病 (IBD) 患者,特别是那些患有克罗恩病 (CD) 患者,可能会患上韦尔尼克脑病 (WE),这是一个罕见的神经复杂症. 及时的维生素B1治疗对于预防这些患者的严重后果至关重要.
科学领域:
- 胃肠病学和神经病学
- 慢性炎症疾病 慢性炎症疾病
- 神经炎症表现的神经炎症表现
背景情况:
- 炎症性肠道疾病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是慢性肠道炎症疾病.
- 肠外表现 (EIM) 在IBD中很常见,但神经系统的参与,包括韦尼克脑病 (WE),是罕见的和不太了解.
- 维尼克脑病变 (WE) 影响中枢神经系统,在一般人群中患病率为0.04%-0.13%,但IBD患者的发生情况尚未得到充分记录.
研究的目的:
- 为了突出克罗恩病 (CD) 和韦尔尼克脑病 (WE) 之间的罕见关联.
- 强调早期诊断和在IBD患者中迅速治疗WE的重要性.
- 在CD的背景下讨论WE的临床表现和管理.
主要方法:
- 一个患有克罗恩病 (CD) 的病人经历了韦尔尼克脑病 (WE) 的病例报告.
- 关于IBD,CD和神经系统并发症之间的关联的文献综述,特别是WE.
- 临床评估和诊断考虑IBD患者的神经参与.
主要成果:
- 该案例说明了克罗恩病 (CD) 患者维尼克脑病变 (WE) 的具有挑战性的表现.
- 在CD中神经和神经肌肉参与是罕见的,关于其频谱和患病率的数据有限.
- 早期识别和服用维生素B1对于管理WE和预防不可逆转的神经损伤至关重要.
结论:
- 临床医生应在炎症性肠病 (IBD) 患者中保持对韦尼克脑病 (WE) 的高怀疑指数,即使有微妙的神经症状.
- 在广泛的诊断工作之前,对怀疑维尼克脑病 (WE) 的患者,迅速使用维生素B1进行实证治疗至关重要.
- 对韦尼克脑病 (WE) 的及时干预可以预防严重后果,并改善克罗恩病 (CD) 患者的治疗结果.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
263
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
263
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122
Inflammatory Bowel Disease I: Ulcerative Colitis
192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Chronic Bowel Disorders: Introduction
459
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
459


